undamentalytics Newsletter
Sign in

Neuroone Medical Technologies Corp balance sheet

At the end of fiscal 2025, Neuroone Medical Technologies Corp had total assets of $10.8m, total liabilities of $3.7m and shareholders' equity of $7.1m. It held $6.6m in cash against $0 of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Dec 20102012Dec 20112013Dec 20122014Dec 20132015Dec 20142016Dec 20152017Dec 20162021Sept 20212022Sept 20222023Sept 20232024Sept 20242025Sept 2025LTMJun 2026
Cash and equivalents———————785172
Receivables————00—00—011
Inventory———————012322
Total current assets000000171275106
Total assets000000181385116
Accounts payable————000111111
Deferred revenue (current)———————01————
Total current liabilities0000001132222
Short-term debt——————0——0———
Long-term debt00—————000———
Total debt00—0000000—00
Total liabilities0000001132542
Shareholders' equity−0−0−0−0−0−0−07106174
Shares outstanding———————12m16m—31m42m9m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: MLSS vs NMTCNMTC vs WOKNMTC vs NUWENMTC vs NNNN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Neuroone Medical Technologies Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Neuroone Medical Technologies Corp.